SHP2 inhibitors and methods of treating autoimmune and/or glomerulonephritis-associated diseases using SHP2 inhibitors

• 收藏
• 分享

专利权人:

Beth Israel Deaconess Medical Center, Inc.;Indiana University Research & Technology Corporation

发明人:

Zhang, Zhong-Yin,Kontaridis, Maria,Zeng, Li-Fan,Wang, Jianxun

申请号：

AU2014284279

公开号：

AU2014284279A1

申请日:

2014.07.02

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

Methods are disclosed herein for administering a oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitor for treating autoimmune and/or glomerulonephritis-associated diseases, and in particular, Systemic Lupus Erythematosus (SLE).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/